About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
BC Cancer Agency
›
Division of Medical Oncology
›
Top Articles
Division of Medical Oncology
BC Cancer Agency
2.8K
Articles
99.5K
Citations
3.4
avg. Impact Factor
131
h-index
Most Cited Articles of Division of Medical Oncology in 2017
Title
Journal
Year
Citations
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
International Journal of Radiation Oncology Biology Physics
2017
419
Cancer-Associated Mutations in Endometriosis without Cancer
New England Journal of Medicine
2017
310
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
Annals of Oncology
2017
296
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours
Nature Communications
2017
251
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer
International Journal of Radiation Oncology Biology Physics
2017
166
Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2
Gynecologic Oncology
2017
163
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
Lancet Oncology, The
2017
156
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
Nature Genetics
2017
141
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer
European Urology
2017
127
Ventricular arrhythmias and sudden death in patients taking ibrutinib
Blood
2017
120
Scalable whole-genome single-cell library preparation without preamplification
Nature Methods
2017
105
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed
Breast Cancer Research and Treatment
2017
92
Genetic profiling of and in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact
Blood
2017
82
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
Clinical Cancer Research
2017
82
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer
Clinical Cancer Research
2017
81
F-Fluorination of Unactivated C-H Bonds in Branched Aliphatic Amino Acids: Direct Synthesis of Oncological Positron Emission Tomography Imaging Agents
Journal of the American Chemical Society
2017
79
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
Npj Breast Cancer
2017
78
Canadian Lung Cancer Conference 2017
Current Oncology
2017
78
CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion
Nucleic Acids Research
2017
75
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2
Cancer Research
2017
74
CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor
Nature Communications
2017
64
Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer
Annals of Oncology
2017
64
Real-time endoscopic Raman spectroscopy for in vivo early lung cancer detection
Journal of Biophotonics
2017
59
A noninvasive cancer detection strategy based on gold nanoparticle surface-enhanced raman spectroscopy of urinary modified nucleosides isolated by affinity chromatography
Biosensors and Bioelectronics
2017
58
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial
Lancet Oncology, The
2017
58
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.